Status:
RECRUITING
Sequential Genicular Nerve Ablation Prior to Geniculate Artery Embolization in Knee Pain
Lead Sponsor:
Zagazig University
Conditions:
Chronic Knee Pain
Osteoarthritis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate whether performing genicular nerve ablation (GNA) before geniculate artery embolization (GAE) improves pain relief and knee function in patients with chr...
Detailed Description
Background: Chronic knee pain is a prevalent condition affecting a significant portion of the population, often leading to reduced quality of life and functional impairment. Current treatment options...
Eligibility Criteria
Inclusion
- Adults aged 18 to 80 years.
- Diagnosed with chronic knee pain refractory to conservative treatment.
- Able to provide informed consent.
- Agree to follow the study procedures and attend follow-up visits.
Exclusion
- Contraindications to GNA or GAE procedures (e.g., allergy to local anesthetics, active infection at the procedure site).
- Recent knee surgery within the last six months.
- Severe comorbid conditions that may interfere with the study outcomes (e.g., rheumatoid arthritis, other severe autoimmune diseases).
- Current participation in another clinical trial that could interfere with the outcomes of this study.
Key Trial Info
Start Date :
September 29 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06514755
Start Date
September 29 2024
End Date
April 30 2025
Last Update
October 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig University, Faculty of Medicine
Zagazig, Egypt, 44519